Status:
COMPLETED
Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Muhimbili University of Health and Allied Sciences
Conditions:
HIV Infections
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women d...
Detailed Description
This is a randomized clinical trial conducted to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- HIV-positive pregnant women who are between 12 and 27 weeks gestation who intend to stay in Dar es Salaam until delivery.
Exclusion
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
1141 Patients enrolled
Trial Details
Trial ID
NCT00197678
Start Date
November 1 2002
End Date
July 1 2005
Last Update
November 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harvard School of Public Health
Boston, Massachusetts, United States, 02115